Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gualandi

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|August 6, 2000
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of ageA M Raiola, M T Van Lint, T Lamparelli, et al.
Bone Marrow Transplantation|September 22, 1999
Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubinA Bacigalupo, R Oneto, B Bruno, et al.
Neurology|July 11, 2001
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MSG L Mancardi, R Saccardi, M Filippi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplantsA Bacigalupo, T Lamparelli, F Gualandi, et al.
European Journal of Neurology|May 18, 2020
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumabG Boffa, C Lapucci, E Sbragia, et al.
Gene Therapy|November 13, 2009
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexesA Ferlini, P Sabatelli, M Fabris, et al.
Bone Marrow Transplantation|May 1, 1997
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantationA Bacigalupo, M Soracco, F Vassallo, et al.
Neuromuscular Disorders : NMD|March 8, 2013
Duchenne muscular dystrophy and epilepsyM Pane, S Messina, C Bruno, et al.
Neuromuscular Disorders : NMD|June 19, 2012
Brody syndrome: a clinically heterogeneous entity distinct from Brody disease: a review of literature and a cross-sectional clinical study in 17 patientsN C Voermans, A E Laan, A Oosterhof, et al.
Bone Marrow Transplantation|June 4, 2015
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an updateA Bacigalupo, A Dominietto, A Ghiso, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|August 6, 2000
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of ageA M Raiola, M T Van Lint, T Lamparelli, et al.
Bone Marrow Transplantation|September 22, 1999
Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubinA Bacigalupo, R Oneto, B Bruno, et al.
Neurology|July 11, 2001
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MSG L Mancardi, R Saccardi, M Filippi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplantsA Bacigalupo, T Lamparelli, F Gualandi, et al.
European Journal of Neurology|May 18, 2020
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumabG Boffa, C Lapucci, E Sbragia, et al.
Gene Therapy|November 13, 2009
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexesA Ferlini, P Sabatelli, M Fabris, et al.
Bone Marrow Transplantation|May 1, 1997
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantationA Bacigalupo, M Soracco, F Vassallo, et al.
Neuromuscular Disorders : NMD|March 8, 2013
Duchenne muscular dystrophy and epilepsyM Pane, S Messina, C Bruno, et al.
Neuromuscular Disorders : NMD|June 19, 2012
Brody syndrome: a clinically heterogeneous entity distinct from Brody disease: a review of literature and a cross-sectional clinical study in 17 patientsN C Voermans, A E Laan, A Oosterhof, et al.
Bone Marrow Transplantation|June 4, 2015
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an updateA Bacigalupo, A Dominietto, A Ghiso, et al.
Pageof 14